University Hospital Düsseldorf / CIO Düsseldorf
Düsseldorf's university hospital, a partner in the CIO cancer centre alliance and a leading site for FAPI and PSMA imaging under Frederik Giesel.
Overview
University Hospital Düsseldorf forms, with Aachen, Bonn and Cologne, the Centrum für Integrierte Onkologie (CIO ABCD), a German Cancer Aid Oncology Center of Excellence. Its nuclear medicine department is directed by Frederik Giesel, co-inventor of FAPI PET tracers at Heidelberg, and runs theranostic programmes in prostate and neuroendocrine cancers. The hospital has a large paediatric oncology and haematology department, hepatology and liver cancer programmes, and neurosurgical oncology. Trials from the CIO network give patients access to early-phase immunotherapy and cell therapy studies.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Düsseldorf University Hospital, including child institutions. 442 works · 4,235 citations · 69% open access · 7% clinical trials · 2% reviews.
- Iréne Esposito56 works
- Frederik Lars Giesel48 works
- Tom Luedde35 works
- Tanja Natascha Fehm27 works
- Wolfram Trudo Knoefel24 works
- Yuriko Mori23 works
- Emil Novruzov21 works
- Christoph Roderburg20 works
- Sami Alexander Safi18 works
- Sascha Dietrich18 works
- FAPI and PSMA PET
- Theranostics
- Paediatric oncology
- CIO ABCD
Similar pages
not linked directly; found by shared links- PersonUwe Haberkorn
Shares Heidelberg University Hospital / NCT / DKFZ, FAP-2286 (177Lu / 68Ga), FAP, FAPI PET.
- PersonKen Herrmann
Shares FAP, FAPI PET, PSMA, Lutetium-177 vipivotide tetraxetan.
- PersonRahul Aggarwal
Shares PSMA, Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters).
- IdeaFAP theranostics as a pan-cancer stromal strategy
Shares FAP-2286 (177Lu / 68Ga), FAP, FAPI PET, Radioligand therapy (beta emitters).
- PersonJohannes Czernin
Shares PSMA, Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters).
- IdeaA university cyclotron network with shared regulatory files for new tracers
Shares Frederik Giesel, Heidelberg University Hospital / NCT / DKFZ, FAPI PET, PSMA PET.
- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares PSMA, Lutetium-177 vipivotide tetraxetan, Neuroendocrine tumours, PSMA PET.
- InstitutionAll India Institute of Medical Sciences, New Delhi
Shares FAPI PET, PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.